Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on June 11, 2025

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

BURLINGTON, Mass. and JERUSALEM, June 11, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Research will leverage world’s first AI-enabled screening platform for mapping the therapeutic potential of secreted signaling proteins, developed by Juvena Collaboration aims to accelerate the discovery of treatments that help individuals maintain and …

LeddarTech Provides Corporate Update

LeddarTech Provides Corporate Update

QUEBEC CITY, Canada, June 11, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an AI-powered software company recognized for its innovation in advanced driver assistance systems (ADAS) and autonomous …

LeddarTech fait le point sur son entreprise

LeddarTech fait le point sur son entreprise

QUÉBEC, Canada, 11 juin 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech » ou la « Société ») (NASDAQ : LDTC), une société de logiciels reposant sur l’IA reconnue pour son innovation dans les systèmes avancés d’aide à la conduite (systèmes …

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

- Second-generation norovirus constructs produce statistically significant increases in GI.1 and GII.4 norovirus blocking antibodies (141% and 94%, respectively) compared with first-generation constructs, supporting potential for improved protection …

NextGen Digital Files Preliminary Short Form Base Shelf Prospectus

NextGen Digital Files Preliminary Short Form Base Shelf Prospectus

Fredericton, New Brunswick, June 11, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) is pleased to announce that it has filed a preliminary short form base shelf prospectus with the …

Bitdeer Announces May 2025 Production and Operations Update

Bitdeer Announces May 2025 Production and Operations Update

- Increased self-mining hashrate to 13.6 EH/s on continued deployment of SEALMINERs - Sold and shipped 1.6 EH/s of SEALMINER A2s to external customers SINGAPORE, June 11, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the …

Nscale and Lightning AI Partner to Launch Enterprise-grade AI Studio

Nscale and Lightning AI Partner to Launch Enterprise-grade AI Studio

London, UK, June 11, 2025 (GLOBE NEWSWIRE) -- Makes AI Easier to Build and Faster to Scale for Developers and Enterprise Teams Paris, France – June 11, 2025 – Nscale and Lightning AI today announced a strategic partnership bringing together intuitive AI …

Memo Therapeutics AG Publishes Study in Frontiers in Pharmacology Demonstrating Therapeutic Antibody Transcytosis Across the Kidney Barrier After Intravenous Administration

Memo Therapeutics AG Publishes Study in Frontiers in Pharmacology Demonstrating Therapeutic Antibody Transcytosis Across the Kidney Barrier After Intravenous Administration

Results demonstrate that intravenously administered therapeutic IgG antibodies can be detected in urine, supporting the conclusion that these antibodies are capable of crossing the kidney endothelial barrier This proof-of-concept study provides compelling …

Kymeta definitiert Konenektivität neu mit bahnbrechender Multiband-Antenne

Kymeta definitiert Konenektivität neu mit bahnbrechender Multiband-Antenne

Kymeta schafft Multiband-Konnektivität mit vier gleichzeitigen Strahlen in Ku- und Ka-Band-Frequenzen über eine einzige Antennenöffnung Ein technologischer Quantensprung eröffnet neue Möglichkeiten für den Einsatz von KI in Bereichen wie Verteidigung, …

L’antenne multibande révolutionnaire de Kymeta redéfinit la connectivité

L’antenne multibande révolutionnaire de Kymeta redéfinit la connectivité

Kymeta assure une connectivité multibande grâce à quatre faisceaux simultanés en bandes Ku et Ka avec une seule ouverture d’antenne Les avancées technologiques en matière de connectivité ouvrent la voie au développement de l’IA dans les secteurs de la …

Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board

Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board

MIAMI, June 11, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, today announced the appointment of Dr …

SailPoint Announces Fiscal First Quarter 2026 Results

SailPoint Announces Fiscal First Quarter 2026 Results

Grew ARR 30% year-over-year to $925 million Increased SaaS ARR 39% year-over-year to $574 million Expanded the number of customers with more than $1 million of ARR by 62% year-over-year AUSTIN, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- SailPoint, Inc. ( …

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced the addition of John Maraganore, Ph.D., to the Board of …

AGM Update

AGM Update

Oxford, UK – 11 June 2025: OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, provides an update to coincide with its Annual General Meeting being held at 3pm BST today at Windrush Court, Oxford, UK. OXB has …

Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.

Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.

WILLOWBROOK, Ill., June 11, 2025 (GLOBE NEWSWIRE) -- Pharmazz, Inc. ("Pharmazz" or the "Company"), a late-stage biopharmaceutical company developing innovative therapies for unmet medical needs in critical care and neurology, has announced a $25 million …

Ligand Announces 2025 Investor Day in New York City

Ligand Announces 2025 Investor Day in New York City

JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at 10 a.m. Eastern Time at the Harvard Club. The event will …

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

WILMETTE, Ill. and HOUSTON, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Company,” “us” and “our”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients …

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress

SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of soquelitinib to treat systemic sclerosis …

FDH Aero to Showcase Unified Structure and Seamless Customer Experience at the 55th International Paris Air Show

FDH Aero to Showcase Unified Structure and Seamless Customer Experience at the 55th International Paris Air Show

COMMERCE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- FDH Aero, a trusted, independent supply chain solutions partner for the aerospace and defense industry, is proud to announce its attendance at the 55th International Paris Air Show, taking place June 16– …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service